Cardiorespiratory Fitness Attenuates the Effects of the Metabolic Syndrome on All-cause and Cardiovascular Disease Mortality in Men
Overview
Affiliations
Background: The metabolic syndrome is a prevalent condition that carries with it an increased risk of type 2 diabetes mellitus, cardiovascular disease (CVD), and mortality.
Objective: To determine the relationship between cardiorespiratory fitness (CRF) and mortality in healthy men and in those with the metabolic syndrome.
Methods: The sample included 19 223 men, aged 20 to 83 years, who received a clinical evaluation between 1979 and 1995 with mortality follow-up through December 31, 1996. There were 15 466 healthy men (80.5%) and 3757 men with the metabolic syndrome (19.5%).
Results: A total of 480 deaths (161 due to CVD) occurred during 196 298 man-years of follow-up. After adjustment for age, year of examination, smoking status, alcohol consumption, and parental CVD, the relative risks (RRs) (95% confidence interval) of all-cause and CVD mortality were 1.29 (1.05-1.57) and 1.89 (1.36-2.60), respectively, for men with the metabolic syndrome compared with healthy men. After the inclusion of CRF, the associations were not significant. The RRs comparing unfit with fit men for all-cause mortality were 2.18 (1.66-2.87) in healthy men and 2.01 (1.38-2.93) in men with the metabolic syndrome, whereas the RRs for CVD mortality for unfit vs fit men were 3.21 (2.03-5.07) in healthy men and 2.25 (1.27-3.97) in men with the metabolic syndrome. A significant dose-response relationship between CRF and mortality was also observed in men with the metabolic syndrome.
Conclusion: In this sample, CRF provided a strong protective effect against all-cause and CVD mortality in healthy men and men with the metabolic syndrome.
Mendoza M, Suan N, Lavie C J Funct Morphol Kinesiol. 2024; 9(3).
PMID: 39189216 PMC: 11348267. DOI: 10.3390/jfmk9030131.
Tao Z, Sun X, Sun J, Zhu E BMC Public Health. 2024; 24(1):1019.
PMID: 38609934 PMC: 11010386. DOI: 10.1186/s12889-024-18484-z.
Kugler B, Cao X, Wenger M, Franczak E, McCoin C, Von Schulze A Am J Physiol Regul Integr Comp Physiol. 2023; 325(6):R712-R724.
PMID: 37811712 PMC: 11178297. DOI: 10.1152/ajpregu.00133.2023.
Quesada O, Lauzon M, Buttle R, Wei J, Suppogu N, Cook-Wiens G Am J Prev Cardiol. 2023; 14:100498.
PMID: 37181803 PMC: 10172715. DOI: 10.1016/j.ajpc.2023.100498.
Insulin resistance and cardiovascular disease.
Kosmas C, Bousvarou M, Kostara C, Papakonstantinou E, Salamou E, Guzman E J Int Med Res. 2023; 51(3):3000605231164548.
PMID: 36994866 PMC: 10069006. DOI: 10.1177/03000605231164548.